As of 4:02pm ET
| +0.2411 / +8.97%|
The 2 analysts offering 12-month price forecasts for ImmunoCellular Therapeutics Ltd have a median target of 42.50, with a high estimate of 80.00 and a low estimate of 5.00. The median estimate represents a +1,350.51% increase from the last price of 2.93.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.